查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1753906

2025 年至 2033 年出血性疾病治療市場報告（按類型、藥物類別、配銷通路、最終用戶和地區）

Bleeding Disorders Treatment Market Report by Type, Drug Class, Distribution Channel, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球出血性疾病治療市場規模達 158 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 248 億美元，2025-2033 年期間的成長率 (CAGR) 為 4.87%。

出血性疾病包括血友病A和B、血管性血友病、特發性血小板減少性紫斑症 (ITP) 以及維生素K和因子II、V、VII、X和XII缺乏症。它們是一類會擾亂個體血液凝固過程的疾病。它們還可能導致受傷後大量出血和長時間出血。其症狀包括月經過多、容易瘀青、頻繁流鼻血、輕微割傷出血過多、關節出血。這些疾病的診斷是透過全血球計數 (CBC)、血小板聚集和出血時間等血液檢查進行的。其治療方法包括藥物治療，如腎上腺色素單縮氨基脲、視網膜出血、鼻出血、氨基己酸、抑肽酶和鐵補充劑。這些藥物有助於減輕特定症狀並延長患者的生命。出血性疾病的治療還包括輸血、替代療法以及注射凝血因子和血漿。

出血性疾病治療市場趨勢：

出血性疾病在人群中日益普遍的盛行率以及老年人口的不斷成長（老年人更容易患上此類疾病）是推動全球市場發展的關鍵因素。此外，越來越多的醫療保險政策為出血性疾病治療提供經濟援助並降低醫療費用，這也對市場產生了積極影響。此外，許多國家的管理機構正在提高人們對捐血和血漿捐贈的認知。他們也積極推廣捐血活動。此外，人們對有效治療方案可用性的認知不斷提高，也為市場帶來了積極的前景。此外，研發活動以及醫療基礎設施和診斷技術的顯著改進預計將為市場帶來良好的前景。

本報告回答的關鍵問題：

  • 全球出血性疾病治療市場迄今表現如何，未來幾年將如何表現？
  • COVID-19 對全球出血性疾病治療市場有何影響？
  • 主要的區域市場有哪些？
  • 根據類型，市場區隔是怎樣的？
  • 根據藥品類別，市場是如何分類的？
  • 根據配銷通路，市場如何分類？
  • 根據最終用戶，市場是如何分類的？
  • 該產業的價值鏈分為哪些階段？
  • 該行業的主要促進因素和挑戰是什麼？
  • 全球出血性疾病治療市場的結構是如何的？主要參與者是誰？
  • 產業競爭程度如何？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球出血性疾病治療市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依類型

  • 血友病A
  • 血友病B
  • 血管性血友病
  • 其他

第7章：市場區隔：依藥品類別

  • 血漿來源的凝血因子濃縮物
    • 關鍵部分
      • 第八因子
      • 凝血因子IX
      • 血管性血友病的因素
      • 活性凝血酶原複合物濃縮物
  • 重組凝血因子濃縮物
    • 關鍵部分
      • 第八因子
      • 血管性血友病的因素
      • 凝血因子IX
  • 去氨加壓素
  • 抗纖溶藥物
  • 纖維蛋白密封劑
  • 其他

第8章：市場區隔：按配銷通路

  • 醫院藥房
  • 零售藥局
  • 網路商店

第9章：市場區隔：依最終用戶

  • 醫院
  • 診所
  • 學術和研究機構

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AbbVie Inc
    • Alnylam Pharmaceuticals Inc.
    • Bayer AG
    • CSL Behring (CSL Limited)
    • Grifols SA
    • Johnson & Johnson
    • Novo Nordisk A/S
    • Octapharma AG
    • Pfizer Inc.
    • Sanofi SA
    • Takeda Pharmaceutical Company Limited
    • Wellona Pharma
Product Code: SR112025A6567

The global bleeding disorders treatment market size reached USD 15.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 24.8 Billion by 2033, exhibiting a growth rate (CAGR) of 4.87% during 2025-2033.

Bleeding disorders involve hemophilia A and B, Von Willebrand disease, idiopathic thrombocytopenic purpura (ITP), and deficiencies of vitamin K and factors II, V, VII, X, and XII. They are a class of conditions that disrupt the blood clotting process in an individual. They can also lead to heavy and prolonged bleeding after an injury. They have symptoms, including heavy menstrual bleeding, easy bruising, frequent nosebleeds, excessive bleeding from minor cuts, and joint bleeding. They are diagnosed through blood tests of complete blood count (CBC), platelet aggregation, and bleeding time. Their treatment comprises medications, including adrenochrome monosemicarbazone, retinal hemorrhage, epistaxis, aminocaproic acid, aprotinin, and iron supplements. These medications can aid in minimizing specific symptoms and prolonging the life of patients. Bleeding disorders treatment also includes blood transfusion, replacement therapy, and injections of a clotting factor and plasma.

Bleeding Disorders Treatment Market Trends:

The increasing prevalence of bleeding disorders among the masses and the rising geriatric population, which is more susceptible to these medical conditions, are among the key factors driving the market around the world. Moreover, the growing adoption of health insurance policies that provide financial assistance for bleeding disorders treatment and reduce healthcare expenses is influencing the market positively. In addition, governing agencies of numerous countries are generating awareness about blood and plasma donation. They are also undertaking initiatives to promote blood donation camps. Apart from this, the increasing awareness about the availability of effective treatment alternatives is creating a positive outlook for the market. Furthermore, research and development (R&D) activities and considerable improvements in the healthcare infrastructure and diagnostic technologies are expected to provide a favorable outlook to the market.

Key Market Segmentation:

Breakup by Type:

  • Hemophilia A
  • Hemophilia B
  • Von Willebrand Disease
  • Others

Breakup by Drug Class:

  • Plasma-derived Coagulation Factor Concentrates
    • Factor VIII
    • Factor IX
    • Factor for Von Willebrand Disease
    • Activated Prothrombin Complex Concentrate
  • Recombinant Coagulation Factor Concentrates
    • Factor VIII
    • Factor for Von Willebrand Disease
    • Factor IX
  • Desmopressin
  • Antifibrinolytics
  • Fibrin Sealants
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores

Breakup by End User:

  • Hospitals
  • Clinics
  • Academic and Research Institutes

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc, Alnylam Pharmaceuticals Inc., Bayer AG, CSL Behring (CSL Limited), Grifols S.A., Johnson & Johnson, Novo Nordisk A/S, Octapharma AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Wellona Pharma.

Key Questions Answered in This Report:

  • How has the global bleeding disorders treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global bleeding disorders treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global bleeding disorders treatment market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bleeding Disorders Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Hemophilia A
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Hemophilia B
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Von Willebrand Disease
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Drug Class

  • 7.1 Plasma-derived Coagulation Factor Concentrates
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Factor VIII
      • 7.1.2.2 Factor IX
      • 7.1.2.3 Factor for Von Willebrand Disease
      • 7.1.2.4 Activated Prothrombin Complex Concentrate
    • 7.1.3 Market Forecast
  • 7.2 Recombinant Coagulation Factor Concentrates
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Factor VIII
      • 7.2.2.2 Factor for Von Willebrand Disease
      • 7.2.2.3 Factor IX
    • 7.2.3 Market Forecast
  • 7.3 Desmopressin
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Antifibrinolytics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Fibrin Sealants
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Academic and Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AbbVie Inc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Alnylam Pharmaceuticals Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 CSL Behring (CSL Limited)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Grifols S.A.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Novo Nordisk A/S
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Octapharma AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 SWOT Analysis
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sanofi S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Takeda Pharmaceutical Company Limited
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Wellona Pharma
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Bleeding Disorders Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Bleeding Disorders Treatment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Bleeding Disorders Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Bleeding Disorders Treatment Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Bleeding Disorders Treatment Market: Breakup by Drug Class (in %), 2024
  • Figure 6: Global: Bleeding Disorders Treatment Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Bleeding Disorders Treatment Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Bleeding Disorders Treatment Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Bleeding Disorders Treatment (Hemophilia A) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Bleeding Disorders Treatment (Hemophilia A) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Bleeding Disorders Treatment (Hemophilia B) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Bleeding Disorders Treatment (Hemophilia B) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Bleeding Disorders Treatment (Von Willebrand Disease) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Bleeding Disorders Treatment (Von Willebrand Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Bleeding Disorders Treatment (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Bleeding Disorders Treatment (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Bleeding Disorders Treatment (Plasma-derived Coagulation Factor Concentrates) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Bleeding Disorders Treatment (Plasma-derived Coagulation Factor Concentrates) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Bleeding Disorders Treatment (Recombinant Coagulation Factor Concentrates) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Bleeding Disorders Treatment (Recombinant Coagulation Factor Concentrates) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Bleeding Disorders Treatment (Desmopressin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Bleeding Disorders Treatment (Desmopressin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Bleeding Disorders Treatment (Antifibrinolytics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Bleeding Disorders Treatment (Antifibrinolytics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Bleeding Disorders Treatment (Fibrin Sealants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Bleeding Disorders Treatment (Fibrin Sealants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Bleeding Disorders Treatment (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Bleeding Disorders Treatment (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Bleeding Disorders Treatment (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Bleeding Disorders Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Bleeding Disorders Treatment (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Bleeding Disorders Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Bleeding Disorders Treatment (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Bleeding Disorders Treatment (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Bleeding Disorders Treatment (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Bleeding Disorders Treatment (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Bleeding Disorders Treatment (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Bleeding Disorders Treatment (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Bleeding Disorders Treatment (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Bleeding Disorders Treatment (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: North America: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: North America: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: United States: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: United States: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Canada: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Canada: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Asia-Pacific: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Asia-Pacific: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: China: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: China: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Japan: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Japan: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: India: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: India: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: South Korea: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: South Korea: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Australia: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Australia: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Indonesia: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Indonesia: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Others: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Others: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Europe: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Europe: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Germany: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Germany: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: France: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: France: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: United Kingdom: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: United Kingdom: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Italy: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Italy: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Spain: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Spain: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Russia: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Russia: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Latin America: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Latin America: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Brazil: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Brazil: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Mexico: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Mexico: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Others: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Others: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Middle East and Africa: Bleeding Disorders Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Middle East and Africa: Bleeding Disorders Treatment Market: Breakup by Country (in %), 2024
  • Figure 89: Middle East and Africa: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 90: Global: Bleeding Disorders Treatment Industry: SWOT Analysis
  • Figure 91: Global: Bleeding Disorders Treatment Industry: Value Chain Analysis
  • Figure 92: Global: Bleeding Disorders Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bleeding Disorders Treatment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Bleeding Disorders Treatment Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Bleeding Disorders Treatment Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
  • Table 4: Global: Bleeding Disorders Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Bleeding Disorders Treatment Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Bleeding Disorders Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Bleeding Disorders Treatment Market: Competitive Structure
  • Table 8: Global: Bleeding Disorders Treatment Market: Key Players